Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
JJ-Pharma Co.,Ltd. logo
520ATSE Growth

J-Pharma Co.,Ltd.

ジェイファーマ Yahoo Finance

Recent & upcoming events

Aug 12
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 25
Shareholder meeting 21:00
Shareholders' meeting
Venue: ビジョンセンターグランデ東京浜松町 701号室（UD芝大門ビル）、東京都港区芝大門一丁目13番9号（受付開始 午前9時30分） Details
Add to Google Calendar
May 14
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 11
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
2027
Feb 10
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
May 12
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Aug 4
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue —
Operating income ¥-3.71B
Net income ¥-2.47B YoY —
EPS —
P/E —
ROE —

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue — —
Operating income ¥-2.84B —
Net income ¥-2.84B —
EPS ¥-158 —

Quarterly fundamentals

Income & cash flow
Quarter FY25 Q4
Revenue ¥0
Operating income ¥-485M
Net income ¥-448M
Operating CF —

F-Score (Piotroski)

2/9 6 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✗ Positive ROA ROA -51.8%
— Positive operating cash flow No data
✓ ROA improved YoY -52.5% → -51.8%
— Operating CF exceeds net income (accrual quality) No data
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 83.2% → 92.0%
— Current ratio improved No data
— No dilution (shares outstanding did not increase) No data
— Gross margin improved No data
— Asset turnover improved No data

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio —
Current ratio —
Years of positive operating CF 0 of last 2 yrs
Payout ratio —
Latest fiscal year result Loss (net loss ¥2.47B)

Performance history

Last 10 years
0百万円0百万円0百万円0百万円0百万円 FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY24FY25FY26
Revenue 0.000.00—
Operating income -16.3-15.0-37.1
Ordinary income ——-26.4
Net income -16.5-15.0-24.7
Total assets 12.128.647.6
Equity 9.5023.843.8

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: ¥100M
Item FY24FY25FY26
EPS ¥-93——
ROE -173.9%-63.0%—
Operating CF -14.7-15.9—
Investing CF -0.190.00—
Financing CF 9.2529.2—
FCF -14.2-17.0—

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

Debt-free ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data